{"id":"W2804885025","doi":"10.1177/1756286418774338","title":"Phase IV study of retention on fingolimod <i>versus</i> injectable multiple sclerosis therapies: a randomized clinical trial","year":2018,"lang":"en","type":"article","venue":"Therapeutic Advances in Neurological Disorders","topic":"Multiple Sclerosis Research Studies","field":"Medicine","cited_by":24,"is_retracted":false,"has_abstract":true,"ca_institutions":"McGill University; NeuroRx Research (Canada)","funders":"Novartis Pharmaceuticals Corporation","keywords":"Fingolimod; Medicine; Multiple sclerosis; Randomized controlled trial; Natalizumab; Relapsing remitting; Clinical trial; Internal medicine; Oncology; Immunology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002292452,0.0003530223,0.00148958,0.000221882,0.0001652219,0.00001761249,0.0003198717,0.0001707392,0.0001452056],"category_scores_gemma":[0.004572982,0.0002361349,0.0003921394,0.0005942606,0.001522864,0.0001661285,0.0001359279,0.000632512,0.0000151312],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00002397502,"about_ca_system_score_gemma":0.00003920923,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00004303702,"about_ca_topic_score_gemma":0.0002172548,"domain_scores_codex":[0.9944722,0.002206318,0.001215347,0.0008044947,0.0007286344,0.0005729898],"domain_scores_gemma":[0.9925968,0.006178096,0.0003550371,0.0005969745,0.0001471696,0.0001259456],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8281413,0.01482161,0.006475265,0.00002269006,0.0002285848,0.000002853704,0.0007483949,0.00003771679,0.0003434905,0.00005244479,0.00001623224,0.1491094],"study_design_scores_gemma":[0.9073664,0.07384894,0.01050665,0.0000577079,0.0001407078,3.404332e-7,0.0008935821,0.004989859,0.00004857463,0.0006809984,0.001254276,0.0002119875],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.990807,0.001063664,0.0004211206,0.0005813492,0.0006414575,0.005279418,0.000007708417,0.00009881994,0.001099452],"genre_scores_gemma":[0.9887744,0.009500186,0.0001808303,0.0007059575,0.0002069252,0.0005711864,0.000006243776,0.0000331366,0.0000211827],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.1488975,"threshold_uncertainty_score":0.9629301,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1835123173007922,"score_gpt":0.4296725863407087,"score_spread":0.2461602690399164,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}